Research outputs
2022
The patient experience of telehealth access and clinical encounters in Australian health care during COVID-19: implications for enhancing integrated care
White, J., Byles, J., & Walley, T. (2022). The patient experience of telehealth access and clinical encounters in Australian health care during COVID-19: implications for enhancing integrated care. Journal of Integrated Care, 30(4), 386-398. doi:10.1108/jica-05-2021-0024
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”
Mukherjee, K., & Walley, T. (2022). Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”. International Journal of Technology Assessment in Health Care, 38(1). doi:10.1017/s0266462322000319
The qualitative experience of telehealth access and clinical encounters in Australian healthcare during COVID-19: implications for policy.
White, J., Byles, J., & Walley, T. (2022). The qualitative experience of telehealth access and clinical encounters in Australian healthcare during COVID-19: implications for policy.. Health research policy and systems, 20(1), 9. doi:10.1186/s12961-021-00812-z
2021
Evaluating Progestogens for Preventing Preterm Birth International Collaborative (EPPPIC): Meta-analysis of Individual Participant Data From Randomised Controlled Trials
Mol, B. W., Wood, S., Rode, L., Tabor, A., Aboulghar, M. M., Porcher, R., . . . Whitlock, E. P. (2021). Evaluating Progestogens for Preventing Preterm Birth International Collaborative (EPPPIC): Meta-analysis of Individual Participant Data From Randomised Controlled Trials. Obstetrical & Gynecological Survey, 76(8), 464-466. doi:10.1097/ogx.0000000000000955
Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials
Stewart, L. A., Simmonds, M., Duley, L., Llewellyn, A., Sharif, S., Walker, R. A. E., . . . Walley, T. (2021). Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. The Lancet, 397(10280), 1183-1194. doi:10.1016/s0140-6736(21)00217-8
2019
‘All the stars were aligned’? The origins of England’s National Institute for Health Research
Atkinson, P., Sheard, S., & Walley, T. (2019). ‘All the stars were aligned’? The origins of England’s National Institute for Health Research. Health Research Policy and Systems, 17(1). doi:10.1186/s12961-019-0491-5
2018
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia
Bettiol, A., Marconi, E., Lombardi, N., Crescioli, G., Gherlinzoni, F., Walley, T., . . . Giusti, P. (2018). Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia. Clinical Drug Investigation, 38(9), 837-844. doi:10.1007/s40261-018-0676-7
A novel approach to sharing all available information from funded health research: the NIHR Journals Library
Wright, D., Williams, E., Bryce, C., le May, A., Stein, K., Milne, R., & Walley, T. (2018). A novel approach to sharing all available information from funded health research: the NIHR Journals Library. Health Research Policy and Systems, 16(1). doi:10.1186/s12961-018-0339-4
2017
Health technology assessment: A potential roadmap for India
Mukherjee, K., Haycox, A., & Walley, T. (2017). Health technology assessment: A potential roadmap for India. International Journal of Medical Science and Public Health, 1. doi:10.5455/ijmsph.2017.1269225012017
2016
The NIHR at 10: Transforming clinical research
Davies, S. C., Walley, T., Smye, S., Cotterill, L., & Whitty, C. J. M. (2016). The NIHR at 10: Transforming clinical research. Clinical Medicine Journal of the Royal College of Physicians of London, 16(6), 501-502. doi:10.7861/clinmedicine.16-6-501
Publicly funded practice-oriented clinical trials: of importance for healthcare payers
Neyt, M., Christiaens, T., Demotes, J., Walley, T., & Hulstaert, F. (2016). Publicly funded practice-oriented clinical trials: of importance for healthcare payers. Journal of Comparative Effectiveness Research, 5(6), 551-560. doi:10.2217/cer-2016-0018
A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital Setting
Owens, L., Kolamunnage-Dona, R., Owens, A., Perkins, L., Butcher, G., Wilson, K., . . . Pirmohamed, M. (2016). A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital Setting. Alcohol and Alcoholism, 51(5), 584-592. doi:10.1093/alcalc/agw023
Patients' expectations of medicines – a review and qualitative synthesis
Dohnhammar, U., Reeve, J., & Walley, T. (2016). Patients' expectations of medicines – a review and qualitative synthesis. Health Expectations, 19(2), 179-193. doi:10.1111/hex.12345
2014
Health Technology Assessment Programme for Iran; A Luxury or Real Need?
Davari, M., Walley, T., & Haycox, A. (2014). Health Technology Assessment Programme for Iran; A Luxury or Real Need?. Journal of Healthcare Information Management.
2012
Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
Raftery, J., Fairbank, E., Douet, L., Dent, L., Price, A., Milne, R., & Walley, T. (2012). Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials. Trials, 13. doi:10.1186/1745-6215-13-140
Translating comparative effectiveness research into clinical practice: The UK experience
Walley, T. (2012). Translating comparative effectiveness research into clinical practice: The UK experience. Drugs, 72(2), 163-170. doi:10.2165/11630860-000000000-00000
Health care financing in Iran; Is privatization a good solution?
Davari, M., Haycox, A., & Walley, T. (2012). Health care financing in Iran; Is privatization a good solution?. Iranian Journal of Public Health, 41(7), 14-23.
The Iranian health insurance system; past experiences, present challenges and future strategies
Davari, M., Haycox, A., & Walley, T. (2012). The Iranian health insurance system; past experiences, present challenges and future strategies. Iranian Journal of Public Health, 41(9), 1-9.
2011
The clinical effectiveness and cost-effectiveness of genotyping for <i>CYP2D6</i> for the management of women with breast cancer treated with tamoxifen: a systematic review
Fleeman, N., Martin Saborido, C., Payne, K., Boland, A., Dickson, R., Dundar, Y., . . . Walley, T. (2011). The clinical effectiveness and cost-effectiveness of genotyping for <i>CYP2D6</i> for the management of women with breast cancer treated with tamoxifen: a systematic review. HEALTH TECHNOLOGY ASSESSMENT, 15(33), XIII-+. doi:10.3310/hta15330
A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC)
Owens, L., Butcher, G., Gilmore, I., Kolamunnage-Dona, R., Oyee, J., Perkins, L., . . . Pirmohamed, M. (2011). A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC). BMC PUBLIC HEALTH, 11. doi:10.1186/1471-2458-11-528
Uncertainties page: Research to decrease areas of clinical uncertainty
Farmer, A., Milne, R., & Walley, T. (2011). Uncertainties page: Research to decrease areas of clinical uncertainty. BMJ, 342(7793), 381. doi:10.1136/bmj.d369
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses
Fleeman, N., Dundar, Y., Dickson, R., Jorgensen, A., Pushpakom, S., McLeod, C., . . . Walley, T. (2011). Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses. PHARMACOGENOMICS JOURNAL, 11(1), 1-14. doi:10.1038/tpj.2010.73
Determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia
Magzoub, M. A., Neyaz, Y., Khoja, T., Qureshi, N. A., Haycox, A., & Walley, T. (2011). Determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17, 149-155.
Determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia
Magzoub, M. A., Neyaz, Y., Khoja, T., Qureshi, N. A., Haycox, A., & Walley, T. (2011). Determinants of physicians' medication prescribing behaviour in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17(2), 160-166. doi:10.26719/2011.17.2.160
Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh city, Saudi Arabia
Qureshi, N. A., Neyaz, Y., Khoja, T., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17(2), 172-179. doi:10.26719/2011.17.2.172
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
Fleeman, N., Bagust, A., Boland, A., Dickson, R., Dundar, Y., Moonan, M., . . . Thorp, N. (2011). Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 15(42), 1-+. doi:10.3310/hta15420
Medication errors in primary care in Riyadh city, Saudi Arabia
Khoja, T., Neyaz, Y., Qureshi, N. A., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Medication errors in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17(2), 156-159. doi:10.26719/2011.17.2.156
Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia
Neyaz, Y., Khoja, T., Qureshi, N. A., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17, 160-166.
Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia
Neyaz, Y., Khoja, T., Qureshi, N. A., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Medication prescribing pattern in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17(2), 149-155. doi:10.26719/2011.17.2.149
Pharmaceutical policy and market in Iran: past experiences and future challenges
Davari, M., Walley, T., & Haycox, A. (2011). Pharmaceutical policy and market in Iran: past experiences and future challenges. Journal of Pharmaceutical Health Services Research, 2(1), 47-52. doi:10.1111/j.1759-8893.2011.00042.x
Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 1: Variations in drug prescribing
Neyaz, Y., Qureshi, N. A., Khoja, T., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 1: Variations in drug prescribing. Eastern Mediterranean Health Journal, 17(2), 126-131. doi:10.26719/2011.17.2.126
Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 2: Rational prescribing
Khoja, T., Qureshi, N. A., Neyaz, Y., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 2: Rational prescribing. Eastern Mediterranean Health Journal, 17(2), 132-139. doi:10.26719/2011.17.2.132
Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 3: Prescribing errors
Qureshi, N. A., Neyaz, Y., Khoja, T., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Physicians' medication prescribing in primary care in Riyadh city, Saudi Arabia. Literature review, part 3: Prescribing errors. Eastern Mediterranean Health Journal, 17(2), 140-148. doi:10.26719/2011.17.2.140
Predictors of quality of medication prescribing in primary care in Riyadh city, Saudi Arabia
Neyaz, Y., Khoja, T., Qureshi, N. A., Magzoub, M. A., Haycox, A., & Walley, T. (2011). Predictors of quality of medication prescribing in primary care in Riyadh city, Saudi Arabia. Eastern Mediterranean Health Journal, 17(2), 167-171. doi:10.26719/2011.17.2.167
Research to decrease areas of clinical uncertainty
Farmer, A., Milne, R., & Walley, T. (2011). Research to decrease areas of clinical uncertainty. BMJ 2011, 342:d369.
Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
Silman, A., Rudkin, S., & Walley, T. (2011). Setting the research agenda for future clinical trials on the use of biologics in rheumatology.. Rheumatology Oxford England, 50(8), 1356-1357. doi:10.1093/rheumatology/keq370
2010
Using comparative effectiveness research to inform policy and practice in the UK NHS: Past, present and future
Chalkidou, K., & Walley, T. (2010). Using comparative effectiveness research to inform policy and practice in the UK NHS: Past, present and future. Pharmacoeconomics, 28(10), 799-811. doi:10.2165/11535260-000000000-00000
Drugs, money and society (part II)
Walley, T. (2010). Drugs, money and society (part II). British Journal of Clinical Pharmacology, 70(3), 342-345. doi:10.1111/j.1365-2125.2009.03569.x
Medicines regulation and health technology assessment
Breckenridge, A., Woods, K., & Walley, T. (2010). Medicines regulation and health technology assessment. Clinical Pharmacology and Therapeutics, 87(2), 152-154. doi:10.1038/clpt.2009.261
Research funding in a pandemic
Walley, T., & Davidson, P. (2010). Research funding in a pandemic. Lancet, 375(9720), 1063-1065. doi:10.1016/S0140-6736(10)60068-2
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
Fleeman, N., McLeod, C., Bagust, A., Beale, S., Boland, A., Dundar, Y., . . . Dickson, R. (2010). The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 14(3), 1-+. doi:10.3310/hta14030
Using Comparative Effectiveness Research to Inform Policy and
Chalkidou, K., & Walley, T. (2010). Using Comparative Effectiveness Research to Inform Policy and. Pharmacoeconomics 2010, 28:, 799-811.
2009
Erlotinib for the treatment of relapsed non-small cell lung cancer
McLeod, C., Bagust, A., Boland, A., Hockenhull, J., Dundar, Y., Proudlove, C., . . . Dickson, R. (2009). Erlotinib for the treatment of relapsed non-small cell lung cancer. HEALTH TECHNOLOGY ASSESSMENT, 13, 41-47. doi:10.3310/hta13suppl1/07
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
Dundar, Y., Bagust, A., Hounsome, J., McLeod, C., Boland, A., Davis, H., . . . Dickson, R. (2009). Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma. HEALTH TECHNOLOGY ASSESSMENT, 13, 23-28. doi:10.3310/hta13suppl1/04
Benefit of statins in daily practice? A six-year retrospective observational study
Deambrosis, P., Terrazzani, G., Walley, T., Bader, G., Giusti, P., Debetto, P., & Chinellato, A. (2009). Benefit of statins in daily practice? A six-year retrospective observational study. Pharmacological Research, 60(5), 397-401. doi:10.1016/j.phrs.2009.06.009
A/H1N1 flu: Call for flu research under way
Walley, T. (2009). A/H1N1 flu: Call for flu research under way. BMJ Online, 339(7712), 63. doi:10.1136/bmj.b2731
Call for flu research under way
Walley, T. (2009). Call for flu research under way. The BMJ, 339(jul08 3), b2731. doi:10.1136/bmj.b2731
Erlotinib for the treatment of relapsed non-small cell lung cancer
McLeod, C., Bagust, A., Boland, A., Hockenhull, J., Dundar, Y., Proudlove, C., . . . Dickson, R. (2009). Erlotinib for the treatment of relapsed non-small cell lung cancer. Health Technology Assessment, 13(Suppl 1), 41-47. doi:10.3310/hta13suppl1-07
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma
Dundar, Y., Bagust, A., Hounsome, J., McLeod, C., Boland, A., Davis, H., . . . Dickson, R. (2009). Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma. Health Technology Assessment, 13(Suppl 1), 23-28. doi:10.3310/hta13suppl1/04
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma
Dundar, Y., Bagust, A., Hounsome, J., McLeod, C., Boland, A., Davis, H., . . . Dickson, R. (2009). Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin’s lymphoma. Health Technology Assessment, 13(Suppl 1), 23-28. doi:10.3310/hta13suppl1-04
Clinical research in the National Health Service in England
Walley, T. (2009). Clinical research in the National Health Service in England. Trends in Pharmacological Sciences, 30(9), 449-452. doi:10.1016/j.tips.2009.06.002
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
McLeod, C., Fleeman, N., Kirkham, J., Bagust, A., Boland, A., Chu, P., . . . Walley, T. (2009). Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 13(1), 1-+. doi:10.3310/hta13010
The UK's NHS and pharma: need for more clinical pharmacologists
Aronson, J. K., Barnett, D. B., Breckenridge, A. M., Ferrier, R. E., Jackson, P., Maxwell, S. R., . . . Woods, K. L. (2009). The UK's NHS and pharma: need for more clinical pharmacologists. LANCET, 373(9671), 1251-1252. doi:10.1016/S0140-6736(09)60726-1
The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review
Hockenhull, J. C., Dwan, K. M., Smith, G. W., Gamble, C. L., Boland, A., Walley, T. J., & Dickson, R. C. (2009). The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review. CRITICAL CARE MEDICINE, 37(2), 702-712. doi:10.1097/CCM.0b013e3181958915
2008
Pharmacoeconomics comes of age?
Walley, T., & Breckenridge, A. (2008). Pharmacoeconomics comes of age?. Clinical Pharmacology and Therapeutics, 84(2), 279-280. doi:10.1038/clpt.2008.122
Early access to new medicines
Breckenridge, A., & Walley, T. (2008). Early access to new medicines. Clinical Pharmacology and Therapeutics, 84(1), 23-25. doi:10.1038/clpt.2008.19
Evidence-informed evidence-making
Chalkidou, K., Walley, T., Culyer, A., Littlejohns, P., & Hoy, A. (2008). Evidence-informed evidence-making. Journal of Health Services Research and Policy, 13(3), 167-173. doi:10.1258/jhsrp.2008.008027
Risk sharing and payment by results
Breckenridge, A., & Walley, T. (2008). Risk sharing and payment by results. Clinical Pharmacology and Therapeutics, 83(5), 666-667. doi:10.1038/clpt.2008.15
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull, J. C., Dwan, K., Boland, A., Smith, G., Bagust, A., Dündar, Y., . . . Dickson, R. (2008). The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 12(12).
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation: Abstract
Hockenhull, J. C., Dwan, K., Boland, A., Smith, G., Bagust, A., Duendar, Y., . . . Dickson, R. (2008). The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation: Abstract. HEALTH TECHNOLOGY ASSESSMENT, 12(12), 1-+. Retrieved from https://www.webofscience.com/
Evaluating laboratory diagnostic tests
Walley, T. (2008). Evaluating laboratory diagnostic tests. BMJ, 336(7644), 569-570. doi:10.1136/bmj.39513.576701.80
Do quality incentives change prescribing patterns in primary care? An observational study in Scotland
MacBride-Stewart, S. P., Elton, R., & Walley, T. (2008). Do quality incentives change prescribing patterns in primary care? An observational study in Scotland. Family Practice, 25(1), 27-32. doi:10.1093/fampra/cmm074
Developments for funding clinical research in the UK
Walley, T., & Thakker, R. V. (2008). Developments for funding clinical research in the UK. Lancet, 372(9638), 518-519. doi:10.1016/S0140-6736(08)61214-3
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: A systematic review and economic evaluation
Hockenhull, J. C., Dwan, K., Boland, A., Smith, G., Bagust, A., Dündar, Y., . . . Dickson, R. (2008). The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: A systematic review and economic evaluation. Health Technology Assessment, 12(12). doi:10.3310/hta12120
2007
Health technology assessment in England: Assessment and appraisal
Walley, T. (2007). Health technology assessment in England: Assessment and appraisal. Medical Journal of Australia, 187(5), 283-285. doi:10.5694/j.1326-5377.2007.tb01244.x
Fair pricing for medicines in the UK
Walley, T. (2007). Fair pricing for medicines in the UK. Expert Review of Pharmacoeconomics and Outcomes Research, 7(3), 207-209. doi:10.1586/14737167.7.3.207
Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants
Dowrick, C. F., Hughes, J. G., Hiscock, J. J., Wigglesworth, M., & Walley, T. J. (2007). Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants. BMC HEALTH SERVICES RESEARCH, 7. doi:10.1186/1472-6963-7-64
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Green, J., Dundar, Y., Dodd, S., Dickson, R., & Walley, T. (2007). Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD005574.pub2
Effect of co-treatment with diltiazem on ciclosporin dosage in renal transplant patients
Kumana, C. R., Chan, T. M., Tong, K. L., Li, C. S., Lauder, I. J., & Walley, T. (2007). Effect of co-treatment with diltiazem on ciclosporin dosage in renal transplant patients. Hong Kong Medical Journal, 13(2), 37-39.
Perceptions of the impact of primary care organizations on GP prescribing: The iron fist in the velvet glove?
Prosser, H., & Walley, T. (2007). Perceptions of the impact of primary care organizations on GP prescribing: The iron fist in the velvet glove?. Journal of Health Organization and Management, 21(1), 5-26. doi:10.1108/14777260710732231
Reconciling national treatment policies and drug regulation in Kenya
Amin, A. A., Walley, T., Kokwaro, G. O., Winstanley, P. A., & Snow, R. W. (2007). Reconciling national treatment policies and drug regulation in Kenya. Health Policy and Planning, 22(2), 111-112. doi:10.1093/heapol/czl038
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation. Health Technology Assessment, 11(28), 1-113. doi:10.3310/hta11280
Drug-eluting stents: A systematic review and economic evaluation
Hill, R. A., Boland, A., Dickson, R., Dündar, Y., Haycox, A., McLeod, C., . . . Bagust, A. (2007). Drug-eluting stents: A systematic review and economic evaluation. Health Technology Assessment, 11(46). doi:10.3310/hta11460
Extent of uncollected prescriptions in general practice
Sherratt, M., Andriychenko, D., & Walley, T. (2007). Extent of uncollected prescriptions in general practice. Primary Health Care Research and Development, 8(4), 326-332. doi:10.1017/S1463423607000412
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: A systematic review and economic evaluation
Dundar, Y., Bagust, A., Dickson, R., Dodd, S., Green, J., Haycox, A., . . . Walley, T. (2007). Pemetrexed disodium for the treatment of malignant pleural mesothelioma: A systematic review and economic evaluation. Health Technology Assessment, 11(1). doi:10.3310/hta11010
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation
Dundar, Y., Bagust, A., Dickson, R., Dodd, S., Green, J., Haycox, A., . . . Walley, T. (2007). Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 11(1), 1-+. Retrieved from https://www.webofscience.com/
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Green, J., Dundar, Y., Dodd, S., Dickson, R., & Walley, T. (2007). Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Cochrane Database of Systematic Reviews, (1). doi:10.1002/14651858.CD005574.pub2
2006
The future of health research in the UK
Walley, T., & Raftery, J. (2006). The future of health research in the UK. Lancet, 368(9537), 727. doi:10.1016/S0140-6736(06)69273-8
Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: Does it make a difference?
Dundar, Y., Dodd, S., Williamson, P., Dickson, R., & Walley, T. (2006). Case study of the comparison of data from conference abstracts and full-text articles in health technology assessment of rapidly evolving technologies: Does it make a difference?. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 22(3), 288-294. doi:10.1017/S0266462306051166
Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region
Chinellato, A., Terrazzani, G., Debetto, P., Zambon, P., Guzzinati, S., Walley, T., & Giusti, P. (2006). Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region. British Journal of Clinical Pharmacology, 62(1), 130-133. doi:10.1111/j.1365-2125.2006.02600.x
Searching for and use of conference abstracts in health technology assessments: Policy and practice
Dundar, Y., Dodd, S., Williamson, P., Walley, T., & Dickson, R. (2006). Searching for and use of conference abstracts in health technology assessments: Policy and practice. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 22(3), 283-287. doi:10.1017/S0266462306051154
A pilot study assessing the effectiveness of a decision aid on patient adherence with oral bisphosphonate medication
Oakley, S., & Walley, T. (2006). A pilot study assessing the effectiveness of a decision aid on patient adherence with oral bisphosphonate medication. Pharmaceutical Journal, 276(7399), 536-538.
New drug prescribing by hospital doctors: The nature and meaning of knowledge
Prosser, H., & Walley, T. (2006). New drug prescribing by hospital doctors: The nature and meaning of knowledge. Social Science and Medicine, 62(7), 1565-1578. doi:10.1016/j.socscimed.2005.08.035
New drug prescribing by hospital doctors: The nature and meaning of knowledge
Prosser, H., & Walley, T. (2006). New drug prescribing by hospital doctors: The nature and meaning of knowledge. Social Science & Medicine, 62(7), 1565-1578. doi:10.1016/j.socscimed.2005.08.035
Diagnostics is not Cinderella of health technology assessment [11]
Gabbay, J., & Walley, T. (2006). Diagnostics is not Cinderella of health technology assessment [11]. British Medical Journal, 332(7537), 364-365. doi:10.1136/bmj.332.7537.364-c
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies
Dundar, Y., Dodd, S., Dickson, R., Walley, T., Haycox, A., & Williamson, P. R. (2006). Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technology Assessment, 10(5).
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Green, J., Dundar, Y., Dodd, S., Dickson, R., & Walley, T. (2006). Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. In J. Green (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd005574
Using personal health information in medical research
Walley, T. (2006). Using personal health information in medical research. British Medical Journal, 332(7534), 130-131. doi:10.1136/bmj.332.7534.130
Introducing new health interventions
Gabbay, J., & Walley, T. (2006). Introducing new health interventions. British Medical Journal, 332(7533), 64-65. doi:10.1136/bmj.332.7533.64
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies
Dundar, Y., Dodd, S., Dickson, R., Walley, T., Haycox, A., & Williamson, P. R. (2006). Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. HEALTH TECHNOLOGY ASSESSMENT, 10(5), III-+. Retrieved from https://www.webofscience.com/
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies
Dundar, Y., Dodd, S., Dickson, R., Walley, T., Haycox, A., & Williamson, P. R. (2006). Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technology Assessment, 10(5), 1-162. Retrieved from http://www.hta.ac.uk/project.asp?PjtId=1433
Cost effectiveness of drug eluting coronary artery stenting in a UK setting: Cost-utility study
Bagust, A., Grayson, A. D., Palmer, N. D., Perry, R. A., & Walley, T. (2006). Cost effectiveness of drug eluting coronary artery stenting in a UK setting: Cost-utility study. Heart, 92(1), 68-74. doi:10.1136/hrt.2004.053850
Erlotinib in non-small cell lung cancer - Single Technology Appraisal
Macleod, C., Dickson, R., Whally, T., & Green, J. A. (2006). Erlotinib in non-small cell lung cancer - Single Technology Appraisal. Liverpool: NICE.
Pemetrexed in non-small cell lung cancer: Single technology appraisal
Macleod, C., Dickson, R., Dundar, Y., Whally, T., & Green, J. A. (2006). Pemetrexed in non-small cell lung cancer: Single technology appraisal. Liverpool: NICE.
Pharmaceutical pricing in Europe: Weighing up the options
Mossialos, E., Brogan, D., & Walley, T. (2006). Pharmaceutical pricing in Europe: Weighing up the options. International Social Security Review, 59(3), 3-25. doi:10.1111/j.1468-246X.2006.00245.x
The EurMedStat proposals on indicators for price and utilisation
Walley, T., Folino-Gallo, P., Barry, M., Bruzzone, M., DeJoncheere, K., Rosian, I., . . . Vogler, S. (2006). The EurMedStat proposals on indicators for price and utilisation. Italian Journal of Public Health, 3(1). doi:10.2427/5946
Utilisation of antihyperglycaemic drugs in ten European countries: Different developments and different levels
Melander, A., Folino-Gallo, P., Walley, T., Schwabe, U., Groop, P. H., Klaukka, T., . . . Lindblad, U. (2006). Utilisation of antihyperglycaemic drugs in ten European countries: Different developments and different levels. Diabetologia, 49(9), 2024-2029. doi:10.1007/s00125-006-0331-3
2005
Trends and influences on use of antidiabetic drugs in England, 1992-2003
Walley, T., Hughes, D., & Kendall, H. (2005). Trends and influences on use of antidiabetic drugs in England, 1992-2003. Pharmacoepidemiology and Drug Safety, 14(11), 769-773. doi:10.1002/pds.1089
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003
Walley, T., Folino-Gallo, P., Stephens, P., & Van Ganse, E. (2005). Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. British Journal of Clinical Pharmacology, 60(5), 543-551. doi:10.1111/j.1365-2125.2005.02478.x
Regulating pharmaceutical markets: Improving efficiency and controlling costs in the UK
Walley, T., Mrazek, M., & Mossialos, E. (2005). Regulating pharmaceutical markets: Improving efficiency and controlling costs in the UK. International Journal of Health Planning and Management, 20(4), 375-398. doi:10.1002/hpm.820
Supply and regulation of medicines
Walley, T., Mossialos, E. A., Mrazek, M., & De Joncheere, C. P. (2005). Supply and regulation of medicines. British Medical Journal, 331(7510), 171-172. doi:10.1136/bmj.331.7510.171
Health Technology Assessment and patient safety
Mulcahy, A., & Walley, T. (2005). Health Technology Assessment and patient safety. Italian Journal of Public Health, 2(3-4). doi:10.2427/5961
Direct to consumer marketing [3] (multiple letters)
Duerden, M., Walley, T., & Hochhauser, M. (2005). Direct to consumer marketing [3] (multiple letters). British Medical Journal, 330(7496), 906.
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing
Prosser, H., & Walley, T. (2005). A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing. Social Science and Medicine, 60(6), 1335-1346. doi:10.1016/j.socscimed.2004.07.013
Provider incentives and prescribing behavior in Europe
Mossialos, E., Walley, T., & Rudisill, C. (2005). Provider incentives and prescribing behavior in Europe. Expert Review of Pharmacoeconomics and Outcomes Research, 5(1), 81-93. doi:10.1586/14737167.5.1.81
Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes
Bakhai, A., Hill, R. A., Dundar, Y., Dickson, R., & Walley, T. (2005). Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1), 45 pages. doi:10.1002/14651858.CD004588.pub3
Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.
Duerden, M., & Walley, T. (2005). Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.. BMJ Clinical Research Ed, 330(7496), 906. doi:10.1136/bmj.330.7496.906-a
Drug-eluting stents versus non-drug eluting stents in people with stable angina or acute coronary syndrome
Bakhai, A., Hill, R. A., Dundar, Y., Dickson, R. C., & Walley, T. (2004). Drug-eluting stents versus non-drug eluting stents in people with stable angina or acute coronary syndrome. doi:10.1002/14651858.cd004587
Provider incentives and prescribing behaviour in Europe
Mossialos, E., Walley, T., & Rudisill, C. (2005). Provider incentives and prescribing behaviour in Europe. Expert Rev Pharmacoeconomics Outcomes Res, 5, 1-13.
Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome
Bakhai, A., Hill, R. A., Dundar, Y., Dickson, R., & Walley, T. (2004). Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome. doi:10.1002/14651858.cd004588.pub2
Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome
Bakhai, A., Hill, R. A., Dundar, Y., Dickson, R., & Walley, T. (2002). Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome. doi:10.1002/14651858.cd004588
Supply and regulation of medicines in Central and Eastern Europe
Walley, T., Mossialos, E. A., Mrazek, M., & de Joncheere, C. P. (2005). Supply and regulation of medicines in Central and Eastern Europe. Bmj, 331(7510), 171-172.
When OTC marketing becomes direct to consumer advertising
Duerden, M., & Walley, T. (2005). When OTC marketing becomes direct to consumer advertising. Bmj, 330(7496), 906.
2004
Exploring groups at high risk of restenosis
BAGUST, A., BAKHAI, A., DICKSON, R., DUNDAR, Y., HILL, R., & WALLEY, T. (2004). Exploring groups at high risk of restenosis. European Heart Journal, 25(23), 2168-2169. doi:10.1016/j.ehj.2004.09.028
Pharmacoeconomics for migraine and headache researchers: Basic concepts, methods and terminology
Walley, T. (2004). Pharmacoeconomics for migraine and headache researchers: Basic concepts, methods and terminology. Journal of Headache and Pain, 5(4), 217-223. doi:10.1007/s10194-004-0129-y
The pros and cons of essential medicines for rich countries
Reidenberg, M. M., & Walley, T. (2004). The pros and cons of essential medicines for rich countries. BMJ, 329(7475), 1172. doi:10.1136/bmj.329.7475.1172
Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis
Dündar, Y., Hill, R. A., Bakhai, A., Dickson, R., & Walley, T. (2004). Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 38(4), 200-210. doi:10.1080/14017430410032325
Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe
Walley, T., Folino-Gallo, P., Schwabe, U., Van Ganse, E., & Stephens, P. (2004). Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe. European Journal of Clinical Pharmacology, 60(7), 503-511. doi:10.1007/s00228-004-0801-9
Epidemiology of restless legs syndrome as diagnosed in UK primary care
van de Vijver, D. A. M. C., Walley, T., & Petri, H. (2004). Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Medicine, 5(5), 435-440. doi:10.1016/j.sleep.2004.07.003
Adverse drug reactions as cause of admission to hospital [2] (multiple letters)
Williams, E. R. L., Taylor, R. E., Saunders, D. J., Laws, M. B., Joseph, M., Calder, N. J., . . . Breckenridge, A. M. (2004). Adverse drug reactions as cause of admission to hospital [2] (multiple letters). British Medical Journal, 329(7463), 459-460.
Erratum: Variations and increase in use of statins across Europe: Data from administrative databases (British Medical Journal (2004) 328 (385-386))
Walley, T. (2004). Erratum: Variations and increase in use of statins across Europe: Data from administrative databases (British Medical Journal (2004) 328 (385-386)). British Medical Journal, 329(7461), 323.
Drug-eluting stents: An early systematic review to inform policy
Hill, R. A., Dündar, Y., Bakhai, A., Dickson, R., & Walley, T. (2004). Drug-eluting stents: An early systematic review to inform policy. ACC Current Journal Review, 13(8), 41. doi:10.1016/j.accreview.2004.07.099
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., . . . Breckenridge, A. M. (2004). Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ-BRITISH MEDICAL JOURNAL, 329(7456), 15-19. doi:10.1136/bmj.329.7456.15
Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis
Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 19(5), 305-322. doi:10.1002/hup.594
Drug-eluting stents: an early systematic review to inform policy
Hill, R. A., Dündar, Y., Bakhai, A., Dickson, R., & Walley, T. (2004). Drug-eluting stents: an early systematic review to inform policy. EUROPEAN HEART JOURNAL, 25(11), 902-919. doi:10.1016/j.ehj.2004.03.023
Neuropsychotherapeutics in the UK: What Has Been the Impact of NICE on Prescribing?
Walley, T. (2004). Neuropsychotherapeutics in the UK: What Has Been the Impact of NICE on Prescribing?. CNS Drugs, 18(1), 1-12. doi:10.2165/00023210-200418010-00001
Variations and increase in use of statins across Europe: Data from administrative databases
Walley, T., Folino-Gallo, P., Schwabe, U., & Van Ganse, E. (2004). Variations and increase in use of statins across Europe: Data from administrative databases. British Medical Journal, 328(7436), 385-386. doi:10.1136/bmj.328.7436.385
A framework for containing costs fairly
Light, D., & Walley, T. (2004). A framework for containing costs fairly. In E. Mossialos, T. Walley, & M. Mrazek (Eds.), Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality. Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
Adverse drug reactions as a cause of admission to hospital: a prospective analysis of 18820 patients in two UK hospitals
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A., Walley, T., . . . Breckenridge, A. (2004). Adverse drug reactions as a cause of admission to hospital: a prospective analysis of 18820 patients in two UK hospitals. Bmj, 329(7456), 15-19.
Basic of economics, health economics and pharmacoeconomics
Haycox, A., Boland, A., & Walley, T. (2004). Basic of economics, health economics and pharmacoeconomics. In T. Walley, A. Haycox, & A. Boland (Eds.), Pharmacoeconomics (pp. 1-16). Edinburgh: Churchill Livingstone.
Coronary artery stents: A rapid systematic review and economic evaluation
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dündar, Y., Haycox, A., . . . Walley, T. (2004). Coronary artery stents: A rapid systematic review and economic evaluation. Health Technology Assessment, 8(35). doi:10.3310/hta8350
Coronary artery stents: a rapid systematic review and economic evaluation
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dündar, Y., Haycox, A., . . . Walley, T. (2004). Coronary artery stents: a rapid systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 8(35), 1-+. Retrieved from https://www.webofscience.com/
Coronary artery stents: a rapid systematic review and economic evaluation
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dundar, Y., Haycox, A., . . . Walley, T. (2004). Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess, 8(35), 1-256.
Cost of illness studies
Walley, T., & Strobl, J. (2004). Cost of illness studies. In T. Walley, A. Haycox, & A. Boland (Eds.), Pharmacoeconomics (pp. 85-100). Edinburgh: Churchill Livingstone.
Drug-eluting stents versus non-drug eluting stents in people with stable angina or acute coronary syndrome (Protocol for a Cochrane Review)
Bakhai, A., Hill, R. A., Dundar, Y., Dickson, R., & Walley, T. (2004). Drug-eluting stents versus non-drug eluting stents in people with stable angina or acute coronary syndrome (Protocol for a Cochrane Review). In: The Cochrane Library, (1).
Financial incentives and prescribing
Mossialos, E., & Walley, T. (2004). Financial incentives and prescribing. In E. Mossialos, T. Walley, & M. Mrazek (Eds.), Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (pp. 177-195). Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
Good prescribing practice
Chapman, S., Durieux, P., & Walley, T. (2004). Good prescribing practice. In E. Mossialos, T. Walley, & M. Mrazek (Eds.), Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (pp. 144-157). Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
Dündar, Y., Boland, A., Strobl, J., Dodd, S., Haycox, A., Bagust, A., . . . Walley, T. (2004). Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 8(24), 1-+. Retrieved from https://www.webofscience.com/
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
Dundar, Y., Boland, A., Strobl, J., Dodd, S., Haycox, A., Bagust, A., . . . Walley, T. (2004). Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technology Assessment, 8(24), 1-140.
Pharmacoeconomics
Walley, T., Haycox, A., & Boland, A. (2004). Pharmacoeconomics. Edinburgh: Churchill Livingstone.
Pharmacoeconomics
Walley, T., Haycox, A., & Boland, A. (Eds.) (2004). Pharmacoeconomics. Edinburgh: Churchill Livingstone.
Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality
Mossialos, E., Mrazek, M. F., & Walley, T. (Eds.) (2004). Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality. Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
Regulating pharmaceuticals in Europe: an overview
Mossialos, E., Walley, T., & Mrazek, M. (2004). Regulating pharmaceuticals in Europe: an overview. In Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (pp. 1-37). Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
Should we pay for lifestyle drugs?
Walley, T. (2004). Should we pay for lifestyle drugs?. In E. Mossialos, T. Walley, & M. Mrazek (Eds.), Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality (pp. 297-306). Maidenhead: Open University Press. Retrieved from http://www.euro.who.int/document/E83015.pdf
The economics of healthcare and healthcare systems
McDonald, R., & Walley, T. (2004). The economics of healthcare and healthcare systems. In T. Walley, A. Haycox, & A. Boland (Eds.), Pharmacoeconomics (pp. 17-36). Edinburgh: Churchill Livingstone.
The future challenges
Group, P. R. (2004). The future challenges. In T. Walley, A. Haycox, & A. Boland (Eds.), Pharmacoeconomics (pp. 167-174). Edinburgh: Churchill Livingstone.
The public policy context for pharmacoeconomics
McDonald, R., & Walley, T. (2004). The public policy context for pharmacoeconomics. In T. Walley, A. Haycox, & A. Boland (Eds.), Pharmacoeconomics (pp. 37-54). Edinburgh: Churchill Livingstone.
2003
Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin
Kumana, C. R., Tong, M. K. L., Li, C. S., Lauder, I. J., Lee, J. S. K., Kou, M., . . . Chan, T. M. (2003). Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin. British Journal of Clinical Pharmacology, 56(6), 670-678. doi:10.1046/j.1365-2125.2003.01908.x
PCV36 COST-EFFECTIVENESS OF EARLY THROMBOLYSIS FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW OF THE LITERATURE
Boland, A., Haycox, A. R., Mujita-Mota, R., Dundar, Y., Bagust, A., Dickson, R., & Walley, T. (2003). PCV36 COST-EFFECTIVENESS OF EARLY THROMBOLYSIS FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW OF THE LITERATURE. Value in Health, 6(6), 656. doi:10.1016/s1098-3015(10)61680-4
PNM18 COST-EFFECTIVENESS OF Z DRUGS (ZOLPIDEM, ZOPICLONE AND ZALEPLON) VERSUS BENZODIAZEPINES FOR THE SHORT—TERM MANAGEMENT OF INSOMNIA: A SYSTEMATIC LITERATURE REVIEW
Boland, A., Haycox, A. R., Dundar, Y., Dickson, R., & Walley, T. (2003). PNM18 COST-EFFECTIVENESS OF Z DRUGS (ZOLPIDEM, ZOPICLONE AND ZALEPLON) VERSUS BENZODIAZEPINES FOR THE SHORT—TERM MANAGEMENT OF INSOMNIA: A SYSTEMATIC LITERATURE REVIEW. Value in Health, 6(6), 768. doi:10.1016/s1098-3015(10)61957-2
A reliability study of an instrument for measuring general practitioner consultation skills: the LIV-MAAS scale
Enzer, I., Robinson, J., Pearson, M., Barton, S., & Walley, T. (2003). A reliability study of an instrument for measuring general practitioner consultation skills: the LIV-MAAS scale. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 15(5), 407-412. doi:10.1093/intqhc/mzg056
New drug uptake: Qualitative comparison of high and low prescribing GPs' attitudes and approach
Prosser, H., & Walley, T. (2003). New drug uptake: Qualitative comparison of high and low prescribing GPs' attitudes and approach. Family Practice, 20(5), 583-591. doi:10.1093/fampra/cmg516
EURO-MED-STAT - Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach
Rosian, I., Vogler, S., vander Stichele, R., Larsen, L., Odegaard, B., Brahm, A. K., . . . deJoncheere, K. (2003). EURO-MED-STAT - Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach. European Journal of Public Health, 13(3 Supp), 95-100.
EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: A public health approach
Rosian, I., Vogler, S., vander Stichele, R., Larsen, L., Ødegaard, B., Brahm, A. K., . . . deJoncheere, K. (2003). EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: A public health approach. European Journal of Public Health, 13(3), 95-100. doi:10.1093/eurpub/13.suppl_3.95
Using disease registries for pharmacoepidemiological research: A case study of data from a cystic fibrosis registry
Strobl, J., Enzer, I., Bagust, A., Haycox, A., Smyth, R., Ashby, D., & Walley, T. (2003). Using disease registries for pharmacoepidemiological research: A case study of data from a cystic fibrosis registry. Pharmacoepidemiology and Drug Safety, 12(6), 467-473. doi:10.1002/pds.804
Opioids in Italy: Is marketing more powerful than the law? [4]
Chinellato, A., Terrazzani, G., Walley, T., & Giusti, P. (2003). Opioids in Italy: Is marketing more powerful than the law? [4]. Lancet, 362(9377), 78. doi:10.1016/S0140-6736(03)13819-6
Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling
Hughes, D. (2003). Predicting “real world” effectiveness by integrating adherence with pharmacodynamic modeling. Clinical Pharmacology & Therapeutics, 74(1), 1-8. doi:10.1016/s0009-9236(03)00091-2
Teaching safe and effective prescribing in UK medical schools: A core curriculum for tomorrow's doctors
Maxwell, S., & Walley, T. (2003). Teaching safe and effective prescribing in UK medical schools: A core curriculum for tomorrow's doctors. British Journal of Clinical Pharmacology, 55(6), 496-503. doi:10.1046/j.1365-2125.2003.01878.x
Availability of drugs in the European Union. The case of antiplatelet agents [1]
Sáinz, M., Carvajal, A., Folino Gallo, P., García del Pozo, J., Rosían, I., Vogler, S., . . . deJoncheere, K. (2003). Availability of drugs in the European Union. The case of antiplatelet agents [1]. Medicina Clinica, 120(20), 793-794. doi:10.1016/s0025-7753(03)73846-9
Early thrombosis for the treatment of acute myocardial infarction: A systematic review and economic evaluation
Boland, A., Dundar, Y., Bagust, A., Haycox, A., Hill, R., Mujica Mota, R., . . . Dickson, R. (2003). Early thrombosis for the treatment of acute myocardial infarction: A systematic review and economic evaluation. Health Technology Assessment, 7(15).
Reporting of adverse drug reactions by nurses
Morrison-Griffiths, S., Walley, T. J., Park, B. K., Breckenridge, A. M., & Pirmohamed, M. (2003). Reporting of adverse drug reactions by nurses. LANCET, 361(9366), 1347-1348. doi:10.1016/S0140-6736(03)13043-7
Understanding why GPs see pharmaceutical reprensentatives: A qualitative interview study
Prosser, H., & Walley, T. (2003). Understanding why GPs see pharmaceutical reprensentatives: A qualitative interview study. British Journal of General Practice, 53(489), 305-311.
The EutoMedicines project
Walley, T. (2003). The EutoMedicines project. Journal of Headache and Pain, 4(SUPPL. 1), S59-S62. doi:10.1007/s101940300011
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review
Dundar, Y., Hill, R., Dickson, R., & Walley, T. (2003). Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 96(2), 103-113. doi:10.1093/qjmed/hcg016
Influences on GPs' decision to prescribe new drugs - The importance of who says what
Prosser, H., Almond, S., & Walley, T. (2003). Influences on GPs' decision to prescribe new drugs - The importance of who says what. Family Practice, 20(1), 61-68. doi:10.1093/fampra/20.1.61
Superiority and equivalence in thrombolytic drugs: an interpretation
Walley, T., Dundar, Y., Hill, R., & Dickson, R. (2003). Superiority and equivalence in thrombolytic drugs: an interpretation. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 96(2), 155-160. doi:10.1093/qjmed/hcg020
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.
Boland, A., Dundar, Y., Bagust, A., Haycox, A., Hill, R., Mujica Mota, R., . . . Dickson, R. (2003). Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.. Health Technology Assessment Winchester England, 7(15), 1-136. doi:10.3310/hta7150
Influences on GPs' decision to prescribe new drugs:the importance of who says what
Prosser, H., Almond, S., & Walley, T. (2003). Influences on GPs' decision to prescribe new drugs:the importance of who says what. Fam Pract, 20(1), 61-68.
Oferta de medicamentos en la Unión Europea. El caso de los antiagregantes plaquetarios [Availability of drugs in the European Union. The case of antiplatelet agents]
Sainz, M., Carvajal, A., Folino Gallo, P., Garcia del Pozo, J., & de Investigacion Euro-Med-Sat, G. (2003). Oferta de medicamentos en la Unión Europea. El caso de los antiagregantes plaquetarios [Availability of drugs in the European Union. The case of antiplatelet agents]. Med Clin (Barc), 120, 793-794.
The Euromedicines project
Walley, T. (2003). The Euromedicines project. Journal of Headache and Pain, 4(Supp 1), 59-62.
Treatment for newly diagnosed hypertension: Patterns of prescribing and antihypertensive effectiveness in the UK
Walley, T., Duggan, A. K., Haycox, A. R., & Niziol, C. J. (2003). Treatment for newly diagnosed hypertension: Patterns of prescribing and antihypertensive effectiveness in the UK. Journal of the Royal Society of Medicine, 96(11), 525-531. doi:10.1258/jrsm.96.11.525
Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK
Walley, T., Duggan, A. K., Haycox, A. R., & Niziol, C. J. (2003). Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med, 96(11), 525-531.
2002
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: The outcomes research and economic analysis components of the PROSPER trial
Avorn, J., Benner, J., Ford, I., Ganz, D. A., Gaw, A., Glynn, R. J., . . . Wang, P. S. (2002). Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: The outcomes research and economic analysis components of the PROSPER trial. Controlled Clinical Trials, 23(6), 757-773. doi:10.1016/S0197-2456(02)00228-3
Measuring consultation skills in primary care in England: evaluation and development of content of the MAAS scale
Robinson, J., Walley, T., Pearson, M., Taylor, D., & Barton, S. (2002). Measuring consultation skills in primary care in England: evaluation and development of content of the MAAS scale. BRITISH JOURNAL OF GENERAL PRACTICE, 52(484), 889-893. Retrieved from https://www.webofscience.com/
Using drugs safely
Maxwell, S., Walley, T., & Ferner, R. E. (2002). Using drugs safely. British Medical Journal, 324(7343), 930-931. doi:10.1136/bmj.324.7343.930
A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice
Freemantle, N., Nazareth, I., Eccles, M., Wood, J., Haines, A., Mason, J., . . . Burton, A. (2002). A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. British Journal of General Practice, 52(477), 290-295.
Availability of medicines in the European Union: Results from the EURO-Medicines project
Folino-Gallo, P., Walley, T., Frolich, J. C., Carvajal, A., & Edwards, I. R. (2002). Availability of medicines in the European Union: Results from the EURO-Medicines project. Cancer Chemotherapy and Pharmacology Supplement, 49(7), 441-446.
Lifestyle medicines and the elderly
Walley, T. (2002). Lifestyle medicines and the elderly. Drugs and Aging, 19(3), 163-168. doi:10.2165/00002512-200219030-00001
Medical pharmacology : a clinical core text for integrated curricula with self-assessment
Winstanley, P., & Walley, T. (2002). Medical pharmacology : a clinical core text for integrated curricula with self-assessment. Edinburgh: Churchill Livingstone.
2001
Managing the entry of new medicines in the National Health Service: Health authority experiences and prospects for primary care groups and trusts
McDonald, R., Burrill, P., & Walley, T. (2001). Managing the entry of new medicines in the National Health Service: Health authority experiences and prospects for primary care groups and trusts. Health and Social Care in the Community, 9(6), 341-347. doi:10.1046/j.0966-0410.2001.00312.x
Trends in primary care antibiotic prescribing in England 1994-1998
Unsworth, L., & Walley, T. (2001). Trends in primary care antibiotic prescribing in England 1994-1998. Pharmacoepidemiology and Drug Safety, 10(4), 309-314. doi:10.1002/pds.601
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: A review of the literature
Hughes, D. A., Bagust, A., Haycox, A., & Walley, T. (2001). The impact of non-compliance on the cost-effectiveness of pharmaceuticals: A review of the literature. HEALTH ECONOMICS, 10(7), 601-615. doi:10.1002/hec.609
Investigating Consumer Perspectives on Evaluating Health Technologies
Oliver, S., Milne, R., Bradburn, J., Buchanan, P., Kerridge, L., Walley, T., & Gabbay, J. (2001). Investigating Consumer Perspectives on Evaluating Health Technologies. Evaluation, 7(4), 468-486. doi:10.1177/13563890122209847
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: A review of the literature
Hughes, D. A., Bagust, A., Haycox, A., & Walley, T. (2001). The impact of non-compliance on the cost-effectiveness of pharmaceuticals: A review of the literature. Health Economics, 10(7), 601-615.
Availability of medicines in the European Union: results from the EURO-Medicines project
P., F. -G., T., W., J., F., A., C., & I., E. (2001). Availability of medicines in the European Union: results from the EURO-Medicines project. European Journal of Clinical Pharmacology, 57(6-7), 441-446. doi:10.1007/s002280100345
Accounting for noncompliance in pharmacoeconomic evaluations
Hughes, D. A., Bagust, A., Haycox, A., & Walley, T. (2001). Accounting for noncompliance in pharmacoeconomic evaluations. PHARMACOECONOMICS, 19(12), 1185-1197. doi:10.2165/00019053-200119120-00001
Accounting for noncompliance in pharmacoeconomic evaluations
Hughes, D. A., Bagust, A., Haycox, A., & Walley, T. (2001). Accounting for noncompliance in pharmacoeconomic evaluations. PharmacoEconomics, 19(12), 1185-1197.
Consumers' contributions to a needs led health research programme
Walley, T. (2001). Consumers' contributions to a needs led health research programme. Evaluation, 7, 468-486.
Digest of evidence: smoking cessation and bupropion
Walley, T., & Earl-Slater, A. (2001). Digest of evidence: smoking cessation and bupropion. Br J Clin Governance, 6, 69-74.
Economic Evaluations During Early (Phase II) Drug Development
Hughes, D. A., & Walley, T. (2001). Economic Evaluations During Early (Phase II) Drug Development. PharmacoEconomics, 19(11), 1069-1077. doi:10.2165/00019053-200119110-00001
Effects of a monetary incentive on primary care prescribing in Ireland: Attitudes and perceptions of healthcare professionals and patients
Walley, T., Murphy, M. B., Codd, M., Johnston, Z., & Quirke, T. (2001). Effects of a monetary incentive on primary care prescribing in Ireland: Attitudes and perceptions of healthcare professionals and patients. European Journal of General Practice, 7(3), 92-98. doi:10.3109/13814780109080868
How evidence is reviewed
Walley, T. (2001). How evidence is reviewed. In C. Onion (Ed.), Evidence-based medicine in primary care. RCGP.
Involving consumers in a needs-led research programme: A pilot project
Oliver, S., Milne, R., Bradburn, J., Buchanan, P., Kerridge, L., Walley, T., & Gabbay, J. (2001). Involving consumers in a needs-led research programme: A pilot project. Health Expectations, 4(1), 18-28. doi:10.1046/j.1369-6513.2001.00113.x
Lack of leadership may be a contributory cause (letter)
Parson, K., Evans, S., Breckenridge, A., Calverley, P., Evans, C., Gilmore, I., . . . Winstanley, P. (2001). Lack of leadership may be a contributory cause (letter). Bmj, 322, 1361.
Smoking cessation and bupropion
Earl-Slater, A., & Walley, T. (2001). Smoking cessation and bupropion. British Journal of Clinical Governance, 6(1), 69-74.
Spotlight on insomnia and Zaleplon
Earl-Slater, A., & Walley, T. (2001). Spotlight on insomnia and Zaleplon. British Journal of Clinical Governance, 6(2), 145-148.
The impact of health economics on healthcare delivery: The health economists' perspective
McDonald, R., Haycox, A., & Walley, T. (2001). The impact of health economics on healthcare delivery: The health economists' perspective. Pharmacoeconomics, 19(8), 803-809. doi:10.2165/00019053-200119080-00002
The impact of health economics on healthcare delivery: the health economists' perspective
McDonald, R., Haycox, A., & Walley, T. (2001). The impact of health economics on healthcare delivery: the health economists' perspective. Pharmacoeconomics, 19(8), 803-809.
Why do GPs not implement evidence-based guideline? A descriptive study
Cranney, M., Warren, E., Barton, S., Gardner, K., & Walley, T. (2001). Why do GPs not implement evidence-based guideline? A descriptive study. Family Practice, 18(4), 359-363. doi:10.1093/fampra/18.4.359
2000
An integrated national pharmaceutical policy for the United Kingdom?
Walley, T., Haycox, A., Bagust, A., & Earl-Slater, A. (2000). An integrated national pharmaceutical policy for the United Kingdom?. BMJ, 321(7275), 1523. doi:10.1136/bmj.321.7275.1523
Donepezil and Alzheimer's dementia
Earl-Slater, A., & Walley, T. (2000). Donepezil and Alzheimer's dementia. British Journal of Clinical Governance, 5(1), 47-51.
Effects of a monetary incentive on primary care prescribing in Ireland: Changes in prescribing patterns in one health board 1990-1995
Walley, T., Murphy, M., Codd, M., Johnston, Z., & Quirke, T. (2000). Effects of a monetary incentive on primary care prescribing in Ireland: Changes in prescribing patterns in one health board 1990-1995. Pharmacoepidemiology and Drug Safety, 9(7), 591-598. doi:10.1002/pds.544
Lifestyle medicines
Gilbert, D., Walley, T., & New, B. (2000). Lifestyle medicines. British Medical Journal, 321(7272), 1341-1344. doi:10.1136/bmj.321.7272.1341
Davies textbook of adverse drug reactions
Walley, T. J. (2000). Davies textbook of adverse drug reactions. Postgraduate medical journal, 76(901), 741E. doi:10.1136/pmj.76.901.741e
Data protection legislation: Interpretation and barriers to research
Strobl, J., Cave, E., & Walley, T. (2000). Data protection legislation: Interpretation and barriers to research. British Medical Journal, 321(7265), 890-892. doi:10.1136/bmj.321.7265.890
PMDP4: THE INFLUENCE OF NON-COMPLIANCE ON THE EFFECTIVENESS AND COST-EFFECTIVENESS OF DRUG THERAPIES
Hughes, D., Bagust, A., Haycox, A., & Walley, T. (2000). PMDP4: THE INFLUENCE OF NON-COMPLIANCE ON THE EFFECTIVENESS AND COST-EFFECTIVENESS OF DRUG THERAPIES. Value in Health, 3(5), 373. doi:10.1016/s1098-3015(11)70814-2
Generic prescribing: Time to regulate the market?: Price rises are a blow to nascent primary care groups
Walley, T., & Burrill, P. (2000). Generic prescribing: Time to regulate the market?: Price rises are a blow to nascent primary care groups. BMJ, 320(7228), 131-132. doi:10.1136/bmj.320.7228.131
An alternative to body mass index for standardizing body weight for stature
Bagust, A., & Walley, T. (2000). An alternative to body mass index for standardizing body weight for stature. QJM an International Journal of Medicine, 93(9), 589-596. doi:10.1093/qjmed/93.9.589
Average daily quantities: A tool for measuring prescribing volume in England
Walley, T., & Roberts, D. (2000). Average daily quantities: A tool for measuring prescribing volume in England. Pharmacoepidemiology and Drug Safety, 9(1), 55-58. doi:10.1002/(SICI)1099-1557(200001/02)9:1<55::AID-PDS467>3.0.CO;2-H
Digest of evidence ... pramipexole and Parkinson's disease.
Earl-Slater, A., & Walley, T. (2000). Digest of evidence ... pramipexole and Parkinson's disease.. Clinical Performance and Quality Health Care, 8(4), 240-244.
Donepezil and Alzheimer's dementia.
Earl-Slater, A., & Walley, T. (2000). Donepezil and Alzheimer's dementia.. Clinical Performance and Quality Health Care, 8(1), 47-51.
Feasibility study of multicentre comparison of NHS hospital pharmacy computer data
Walker, P. D., & Walley, T. (2000). Feasibility study of multicentre comparison of NHS hospital pharmacy computer data. British Journal of Clinical Pharmacology, 50(1), 48-54. doi:10.1046/j.1365-2125.2000.00233.x
Outcomes research and biotechnology products: A European view
Walley, T. (2000). Outcomes research and biotechnology products: A European view. Drug Information Journal, 34(1), 185-192. doi:10.1177/009286150003400124
1999
Digest of evidence
Earl-Slater, A., & Walley, T. (1999). Digest of evidence. British Journal of Clinical Governance, 4(2), 72-74.
Outcomes, outcomes research and disease management a view from the UK
Walley, T. (1999). Outcomes, outcomes research and disease management a view from the UK. Disease Management and Health Outcomes, 5(4), 197-207. doi:10.2165/00115677-199905040-00002
A randomized trial of evidence-based outreach (EBOR): Rationale and design
Freemantle, N., Eccles, M., Wood, J., Mason, J., Nazareth, I., Duggan, C., . . . Walley, T. (1999). A randomized trial of evidence-based outreach (EBOR): Rationale and design. Controlled Clinical Trials, 20(5), 479-492. doi:10.1016/S0197-2456(99)00023-9
Addressing barriers to change: An RCT of practice-based education to improve the management of hypertension in the elderly
Cranney, M., Barton, S., & Walley, T. (1999). Addressing barriers to change: An RCT of practice-based education to improve the management of hypertension in the elderly. British Journal of General Practice, 49(444), 522-526.
Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: A study of fundholders and non-fundholders
Wilson, R. P. H., Hatcher, J., Barton, S., & Walley, T. (1999). Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: A study of fundholders and non-fundholders. British Journal of General Practice, 49(443), 431-435.
Importance of health economics must be recognised when trials are designed [5]
Haycox, A., Bagust, A., & Walley, T. (1999). Importance of health economics must be recognised when trials are designed [5]. British Medical Journal, 318(7199), 1696-1697.
The management of Pneumocystis carinii pneumonia
Vilar, F. J., Khoo, S. H., & Walley, T. (1999). The management of Pneumocystis carinii pneumonia. British Journal of Clinical Pharmacology, 47(6), 605-609. doi:10.1046/j.1365-2125.1999.00966.x
Clinical guidelines—the hidden costs
Haycox, A., Bagust, A., & Walley, T. (1999). Clinical guidelines—the hidden costs. BMJ, 318(7180), 391-393. doi:10.1136/bmj.318.7180.391
Treatment of gastro-oesophageal reflux disease in adults
Chassany, O., Bergmann, J. F., Caulin, C., Haycox, A., Barton, S., Walley, T., . . . Scarpignato, C. (1999). Treatment of gastro-oesophageal reflux disease in adults. BMJ, 318(7175), 59. doi:10.1136/bmj.318.7175.59
Treatment of gastro-oesophageal reflux disease in adults
Treatment of gastro-oesophageal reflux disease in adults (1999). BMJ, 318(7175), 59. doi:10.1136/bmj.318.7175.59
Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma
Walley, T., Bundred, P., Rannard, A., & Bogg, J. (1999). Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma. Postgraduate Medical Journal, 75(890), 710-714. doi:10.1136/pgmj.75.890.710
Dermatoeconomics: Quality versus costs in common skin disorder treatments
Geddawl, M., Finlay., Lambert, J. R. M. G., Gieler, U., Vanscheidt, W., Schnellman., & Walley, T. (1999). Dermatoeconomics: Quality versus costs in common skin disorder treatments. In Journal of Dermatological Treatment Vol. 10 (pp. S27-S28).
Prescribing at the interface between primary and secondary care in the UK: Towards joint formularies?
Duerden, M., & Walley, T. (1999). Prescribing at the interface between primary and secondary care in the UK: Towards joint formularies?. Pharmacoeconomics, 15(5), 435-443. doi:10.2165/00019053-199915050-00002
Review of therapeutically equivalent alternatives to short acting beta 2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers
Hughes, D. A., Woodcock, A., & Walley, T. (1999). Review of therapeutically equivalent alternatives to short acting beta 2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers. Thorax, 54(12), 1087-1092. doi:10.1136/thx.54.12.1087
The association of some practice characteristics with antibiotic prescribing
Wilson, R. P. H., Hatcher, J., Barton, S., & Walley, T. (1999). The association of some practice characteristics with antibiotic prescribing. Pharmacoepidemiology and Drug Safety, 8(1), 15-21. doi:10.1002/(SICI)1099-1557(199901/02)8:1<15::AID-PDS386>3.0.CO;2-1
Why health economics matter
Walley, T. (1999). Why health economics matter. In Journal of Dermatological Treatment Vol. 10 (pp. S3-S7).
1998
Rational prescribing in primary care. A role for clinical pharmacology in Europe?
Walley, T. (1998). Rational prescribing in primary care. A role for clinical pharmacology in Europe?. In Methods and Findings in Experimental and Clinical Pharmacology Vol. 20 (pp. 31-35). doi:10.1358/mf.1998.20.1.485629
Review article: Current practice and future perspectives in detection and diagnosis of pancreatic cancer
Haycox, A., Lombard, M., Neoptolemos, J., & Walley, T. (1998). Review article: Current practice and future perspectives in detection and diagnosis of pancreatic cancer. Alimentary Pharmacology and Therapeutics, 12(10), 937-948. doi:10.1046/j.1365-2036.1998.00393.x
Review article: Current treatment and optimal patient management in pancreatic cancer
Haycox, A., Lombard, M., Neoptolemos, J., & Walley, T. (1998). Review article: Current treatment and optimal patient management in pancreatic cancer. Alimentary Pharmacology and Therapeutics, 12(10), 949-964. doi:10.1046/j.1365-2036.1998.00390.x
Prescription charges: Change overdue?: Britain can learn from systems of copayments based on drugs' effectiveness
Walley, T. (1998). Prescription charges: Change overdue?: Britain can learn from systems of copayments based on drugs' effectiveness. BMJ, 317(7157), 487-488. doi:10.1136/bmj.317.7157.487
Auditing the management of hypertension in British general practice: A critical literature review
Cranney, M., Barton, S., & Walley, T. (1998). Auditing the management of hypertension in British general practice: A critical literature review. British Journal of General Practice, 48(432), 1424-1428.
The management of hypertension in the elderly by general practitioners in Merseyside: The rule of halves revisited
Cranney, M., Barton, S., & Walley, T. (1998). The management of hypertension in the elderly by general practitioners in Merseyside: The rule of halves revisited. British Journal of General Practice, 48(429), 1146-1150.
Health technology assessment - The role of the pharmaceutical panel
Walley, T., Rawlins, M., & Stein, K. (1998). Health technology assessment - The role of the pharmaceutical panel. British Journal of Clinical Pharmacology, 45(3), 217-220. doi:10.1046/j.1365-2125.1998.00678.x
'Development of an economic model for the management of upper gastrointestinal disease in primary care: Preliminary findings'
Haycox, A., Butterworth, M., Walley, T., & Barton, S. (1998). 'Development of an economic model for the management of upper gastrointestinal disease in primary care: Preliminary findings'. Pharmacoeconomics, 14(Supple), 11-23.
Clinical guidelines: Ways ahead
Onion, C. W. R., & Walley, T. (1998). Clinical guidelines: Ways ahead. Journal of Evaluation in Clinical Practice, 4(4), 287-293. doi:10.1111/j.1365-2753.1998.tb00088.x
Development of an economic model for the management of upper gastrointestinal disease in primary care: Preliminary findings
Haycox, A. (1998). Development of an economic model for the management of upper gastrointestinal disease in primary care: Preliminary findings. Pharmacoeconomics, 14(SUPPL. 2), 11-23. doi:10.2165/00019053-199814002-00003
Haemodynamic responses in young and elderly, healthy subjects during ambient and warm head-up tilt
Lye, M., & Walley, T. (1998). Haemodynamic responses in young and elderly, healthy subjects during ambient and warm head-up tilt. Clinical Science, 94(5), 493-498. doi:10.1042/cs0940493
Hypertension in the elderly: Attitudes of British patients and general practitioners
Cranney, M., Warren, E., & Walley, T. (1998). Hypertension in the elderly: Attitudes of British patients and general practitioners. Journal of Human Hypertension, 12(8), 539-545. doi:10.1038/sj.jhh.1000656
Miscellaneous antibacterial drugs
Khoo, S. H., & Walley, T. (1998). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 21, 265-281. doi:10.1016/S0378-6080(98)80030-5
Reporting of adverse drug reactions: practice in the UK.
Morrison-Griffiths, S., Pirmohamed, M., & Walley, T. (1998). Reporting of adverse drug reactions: practice in the UK.. Nursing Times, 94(10), 52-54.
The influence of practice characteristics on the prescribing of benzodiazepines and appetite suppressant drugs
Wilson, R. P. H., Hatcher, J., Barton, S., & Walley, T. (1998). The influence of practice characteristics on the prescribing of benzodiazepines and appetite suppressant drugs. Pharmacoepidemiology and Drug Safety, 7(4), 243-251. doi:10.1002/(SICI)1099-1557(199807/08)7:4<243::AID-PDS338>3.0.CO;2-K
1997
Effective high-tech homecare services
Pilling, M., & Walley, T. (1997). Effective high-tech homecare services. Health and Social Care in the Community, 5(2), 142-146.
Miscellaneous antibacterial drugs
Khoo, S. H., & Walley, T. (1997). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 20, 234-249. doi:10.1016/S0378-6080(05)80388-5
The use of health economics by hospital pharmacist decision makers - A survey of UK chief pharmacists
Cooke, J., Walley, T., & Drummond, M. F. (1997). The use of health economics by hospital pharmacist decision makers - A survey of UK chief pharmacists. Pharmaceutical Journal, 259(6968), 729-781.
The UK general practice research database
Walley, T., & Mantgani, A. (1997). The UK general practice research database. Lancet, 350(9084), 1097-1099. doi:10.1016/S0140-6736(97)04248-7
General practice fundholders' prescribing savings in one region of the United Kingdom, 1991-1994
Wilson, R. P. H., Hatcher, J., Barton, S., & Walley, T. (1997). General practice fundholders' prescribing savings in one region of the United Kingdom, 1991-1994. Health Policy, 42(1), 29-37. doi:10.1016/S0168-8510(97)00040-7
Economic evaluation under managed competition: Evidence from the U.K.
Drummond, M., Cooke, J., & Walley, T. (1997). Economic evaluation under managed competition: Evidence from the U.K.. Social Science and Medicine, 45(4), 583-595. doi:10.1016/S0277-9536(96)00398-X
Economic evaluations of drug therapy: Attitudes of primary care prescribing advisers in Great Britain
Walley, T., Barton, S., Cooke, J., & Drummond, M. (1997). Economic evaluations of drug therapy: Attitudes of primary care prescribing advisers in Great Britain. Health Policy, 41(1), 61-72. doi:10.1016/S0168-8510(97)00013-4
The risk of cardiovascular disease in hypertensive patients.
Barton, S., Cranney, M., Hatcher, J., & Walley, T. (1997). The risk of cardiovascular disease in hypertensive patients.. British Journal of General Practice the Journal of the Royal College of General Practitioners, 47(416), 182.
A study of the appropriateness of prescribing in nursing homes
Lunn, J., Chan, K., Donoghue, J., Riley, B., & Walley, T. (1997). A study of the appropriateness of prescribing in nursing homes. International Journal of Pharmacy Practice, 5(1), 6-10. doi:10.1111/j.2042-7174.1997.tb00877.x
Core content of a course in clinical pharmacology
Walley, T., & Webb, D. J. (1997). Core content of a course in clinical pharmacology. British Journal of Clinical Pharmacology, 44(2), 171-174. doi:10.1046/j.1365-2125.1997.00668.x
Developing a core curriculum in clinical pharmacology and therapeutics: A Delphi study
Walley, T., & Webb, D. J. (1997). Developing a core curriculum in clinical pharmacology and therapeutics: A Delphi study. British Journal of Clinical Pharmacology, 44(2), 167-170. doi:10.1046/j.1365-2125.1997.00669.x
Drug rationing in the UK National Health Service: Current status and future prospects
Walley, T., Haycox, A., & Barton, S. (1997). Drug rationing in the UK National Health Service: Current status and future prospects. Pharmacoeconomics, 12(3), 339-350. doi:10.2165/00019053-199712030-00006
Integrating clinical pharmacology in a new problem based medical undergraduate curriculum
Lloyd Jones, G., Walley, T., & Bligh, J. (1997). Integrating clinical pharmacology in a new problem based medical undergraduate curriculum. British Journal of Clinical Pharmacology, 43(1), 15-19. doi:10.1111/j.1365-2125.1997.tb00131.x
Parenteral antibiotics at home in cystic fibrosis experiences and attitudes of recipients
Pilling, M., & Walley, T. (1997). Parenteral antibiotics at home in cystic fibrosis experiences and attitudes of recipients. Health and Social Care in the Community, 5(3), 209-212. doi:10.1111/j.1365-2524.1997.tb00115.x
Pharmacoeconomics: Basic concepts and terminology
Walley, T., & Haycox, A. (1997). Pharmacoeconomics: Basic concepts and terminology. British Journal of Clinical Pharmacology, 43(4), 343-348. doi:10.1046/j.1365-2125.1997.00574.x
Pharmacoeconomics: Evaluating the evaluators
Haycox, A., & Walley, T. (1997). Pharmacoeconomics: Evaluating the evaluators. British Journal of Clinical Pharmacology, 43(5), 451-456. doi:10.1046/j.1365-2125.1997.00575.x
Pharmacoeconomics: Integrating economic evaluation into clinical trials
Haycox, A., Drummond, M., & Walley, T. (1997). Pharmacoeconomics: Integrating economic evaluation into clinical trials. British Journal of Clinical Pharmacology, 43(6), 559-562. doi:10.1046/j.1365-2125.1997.00576.x
Pre-hospital thrombolysis [2] (multiple letters)
Burrell, A., Hall, A., Barton, S., & Walley, T. (1997). Pre-hospital thrombolysis [2] (multiple letters). Pharmacoeconomics, 11(6), 608-609. doi:10.2165/00019053-199711060-00010
Report on VI World Congress on Clinical Pharmacology and Therapeutics, Buenos Aires, 4-9 August 1996
Walley, T. (1997). Report on VI World Congress on Clinical Pharmacology and Therapeutics, Buenos Aires, 4-9 August 1996. In British Journal of Clinical Pharmacology Vol. 43 (pp. 21). doi:10.1111/j.1365-2125.1997.tb00027.x
Should health economics fall within the remit of the physician?
Walley, T. J. (1997). Should health economics fall within the remit of the physician?. International Journal of Pharmaceutical Medicine, 11(1), 11-13.
The use of health economics to support clinical decision making in gastroenterology
Haycox, A., Walley, T., & Barton, S. (1997). The use of health economics to support clinical decision making in gastroenterology. Gastroenterology International, 10(2), 50-52.
Withdrawal of antihypertensive drugs
Cranney, M., & Walley, T. (1997). Withdrawal of antihypertensive drugs. Prescribers Journal, 37(3), 145-150.
1996
Patient packs and the prescribing of antimicrobial agents
Humphreys, H., & Walley, T. (1996). Patient packs and the prescribing of antimicrobial agents. Journal of Antimicrobial Chemotherapy, 38(3), 329-331. doi:10.1093/jac/38.3.329
Study did not take account of confounders
Haycox, A., Barton, S., & Walley, T. (1996). Study did not take account of confounders. BMJ, 313(7065), 1142.3-1143. doi:10.1136/bmj.313.7065.1142b
Effects of fundholding on prescribing habits
Wilson, R., & Walley, T. (1996). Effects of fundholding on prescribing habits. BMJ, 312(7034), 848. doi:10.1136/bmj.312.7034.848
Local clinical guidelines: Description and evaluation of a participative method for their development and implementation
Onion, C. W. R., Dutton, C. E., Walley, T., Turnbull, C. J., Dunne, W. T., & Buchan, I. E. (1996). Local clinical guidelines: Description and evaluation of a participative method for their development and implementation. FAMILY PRACTICE, 13(1), 28-34. doi:10.1093/fampra/13.1.28
Commercialisation of disease management [12]
Walley, T., & Barton, S. (1996). Commercialisation of disease management [12]. Lancet, 347(9017), 1768-1769. doi:10.1016/S0140-6736(96)90848-X
Comparing hypertension guidelines. Technical difficulties may have affected study's results.
Barton, S., Cranney, M., & Walley, T. (1996). Comparing hypertension guidelines. Technical difficulties may have affected study's results.. BMJ Clinical Research Ed, 313(7066), 1204. doi:10.1136/bmj.313.7066.1204
Contracting for high-tech health care for patients at home: a survey of purchaser responses.
Pilling, M., & Walley, T. (1996). Contracting for high-tech health care for patients at home: a survey of purchaser responses.. Journal of Management in Medicine, 10(6), 2-17. doi:10.1108/02689239610153168
Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics
Barton, S., & Walley, T. (1996). Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics. Pharmacoeconomics, 10(5), 441-452. doi:10.2165/00019053-199610050-00001
Effective contracting of high-tech health care for patients at home.
Pilling, M., & Walley, T. (1996). Effective contracting of high-tech health care for patients at home.. Journal of Management in Medicine, 10(3), 6-14. doi:10.1108/02689239610122261
Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: An observational study
Wilson, R. P. H., Hatcher, J., Barton, S., & Walley, T. (1996). Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: An observational study. British Medical Journal, 313(7057), 595-599. doi:10.1136/bmj.313.7057.595
Same information, different decisions: The influence of evidence on the management of hypertension in the elderly
Cranney, M., & Walley, T. (1996). Same information, different decisions: The influence of evidence on the management of hypertension in the elderly. British Journal of General Practice, 46(412), 661-663.
1995
Prescribing costs in general practice fundholding
Wilson, R., & Walley, T. (1995). Prescribing costs in general practice fundholding. Lancet, 346(8991-8892), 1710-1711. doi:10.1016/S0140-6736(95)92877-4
Miscellaneous antibacterial drugs
Khoo, S., & Walley, T. (1995). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 19(C), 245-256. doi:10.1016/S0378-6080(05)80151-5
ALTERATIONS IN PRESCRIBING BY GENERAL-PRACTITIONER FUNDHOLDERS - AN OBSERVATIONAL STUDY
WILSON, R. P. H., BUCHAN, I., & WALLEY, T. (1995). ALTERATIONS IN PRESCRIBING BY GENERAL-PRACTITIONER FUNDHOLDERS - AN OBSERVATIONAL STUDY. BRITISH MEDICAL JOURNAL, 311(7016), 1347-1350. doi:10.1136/bmj.311.7016.1347
Bayer promotional publications misleading about effect of ciprofloxacin on hospital admissions
Barton, S. B., & Walley, T. (1995). Bayer promotional publications misleading about effect of ciprofloxacin on hospital admissions. Lancet, 346(8982), 1102. doi:10.1016/S0140-6736(95)91776-4
A purchaser perspective of managing new drugs: Interferon beta as a case study
Walley, T., & Barton, S. (1995). A purchaser perspective of managing new drugs: Interferon beta as a case study. BMJ, 311(7008), 796. doi:10.1136/bmj.311.7008.796
Upper gastrointestinal endoscopy
Walley, T. (1995). Upper gastrointestinal endoscopy. BMJ, 311(6996), 57. doi:10.1136/bmj.311.6996.57c
A UK National Prescribing List?
Walley, T. (1995). A UK National Prescribing List?. Pharmacoeconomics, 7(6), 471-474. doi:10.2165/00019053-199507060-00001
Clinical guidelines: Development, implementation, and effectiveness
Onion, C. W. R., & Walley, T. (1995). Clinical guidelines: Development, implementation, and effectiveness. Postgraduate Medical Journal, 71(831), 3-9. doi:10.1136/pgmj.71.831.3
Current Prescribing in Primary Care in the UK: Effects of the Indicative Prescribing Scheme and GP Fundholding
Walley, T., Wilson, R., & Bligh, J. (1995). Current Prescribing in Primary Care in the UK: Effects of the Indicative Prescribing Scheme and GP Fundholding. Pharmacoeconomics, 7(4), 320-331. doi:10.2165/00019053-199507040-00006
Drugs, money and society.
Walley, T. (1995). Drugs, money and society.. British Journal of Clinical Pharmacology, 39(4), 343-345. doi:10.1111/j.1365-2125.1995.tb04461.x
Haemoptysis in a pregnant woman with repaired aortic coarctation
Ng, K., & Walley, T. J. (1995). Haemoptysis in a pregnant woman with repaired aortic coarctation. British Journal of Cardiology, 2(6), 176-178.
Pharmacoeconomics: a challenge for clinical pharmacologists.
Walley, T., & Davey, P. (1995). Pharmacoeconomics: a challenge for clinical pharmacologists.. British Journal of Clinical Pharmacology, 40(3), 199-202. doi:10.1111/j.1365-2125.1995.tb05775.x
Prescribing in the elderly
Walley, T., & Scott, A. K. (1995). Prescribing in the elderly. Postgraduate Medical Journal, 71(838), 466-471. doi:10.1136/pgmj.71.838.466
This letter was shown to the authors, who reply as follows
Walley, T. (1995). This letter was shown to the authors, who reply as follows. Postgraduate Medical Journal, 71(839), 575. doi:10.1136/pgmj.71.839.575-a
1994
'This house believes that pharmacoeconomic analysis should be mandated by governments rather than left to market forces'.
Eisenberg, J. M., Evans, D. B., Walley, T., & Lovatt, B. (1994). 'This house believes that pharmacoeconomic analysis should be mandated by governments rather than left to market forces'.. Pharmacoeconomics, 6(4), 352-357.
LACK OF PHARMACODYNAMIC INTERACTIONS BETWEEN ACUTE DOSE FLOSEQUINAN AND XAMOTEROL - A PILOT-STUDY IN HEALTHY-SUBJECTS
NG, H. W. K., WALLEY, T. J., TSAO, Y., & BRECKENRIDGE, A. M. (1994). LACK OF PHARMACODYNAMIC INTERACTIONS BETWEEN ACUTE DOSE FLOSEQUINAN AND XAMOTEROL - A PILOT-STUDY IN HEALTHY-SUBJECTS. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 46(4), 361-365. Retrieved from https://www.webofscience.com/
Allergic Drug Reactions: Incidence and Avoidance
Walley, T., & Coleman, J. W. (1994). Allergic Drug Reactions: Incidence and Avoidance. Clinical Immunotherapeutics, 1(2), 101-109. doi:10.1007/BF03258496
COMPARISON OF THERMODILUTION, THORACIC ELECTRICAL BIOIMPEDANCE AND DOPPLER ULTRASOUND CARDIAC-OUTPUT MEASUREMENT
NG, H. W. K., WALLEY, T. J., & MOSTAFA, S. M. (1994). COMPARISON OF THERMODILUTION, THORACIC ELECTRICAL BIOIMPEDANCE AND DOPPLER ULTRASOUND CARDIAC-OUTPUT MEASUREMENT. BRITISH JOURNAL OF ANAESTHESIA, 73(1), 119-120. doi:10.1093/bja/73.1.119-b
Clinical pharmacology and therapeutics in undergraduate medical education in the UK: current status.
Walley, T., Bligh, J., Orme, M., & Breckenridge, A. (1994). Clinical pharmacology and therapeutics in undergraduate medical education in the UK: current status.. British Journal of Clinical Pharmacology, 37(2), 129-135. doi:10.1111/j.1365-2125.1994.tb04252.x
Clinical pharmacology and therapeutics in undergraduate medical education in the UK: the future.
Walley, T., Bligh, J., Orme, M., & Breckenridge, A. (1994). Clinical pharmacology and therapeutics in undergraduate medical education in the UK: the future.. British Journal of Clinical Pharmacology, 37(2), 137-143. doi:10.1111/j.1365-2125.1994.tb04253.x
Is there a Need for an Independent Centre for Pharmacoeconomics in the UK?
Walley, T., & Edwards, R. T. (1994). Is there a Need for an Independent Centre for Pharmacoeconomics in the UK?. Pharmacoeconomics, 5(2), 93-100. doi:10.2165/00019053-199405020-00003
Therapeutic conservatism [1]
Walley, T. (1994). Therapeutic conservatism [1]. Journal of the Royal College of Physicians of London, 28(1), 86-87.
1993
EJECTION FRACTION BY TRANSTHORACIC ELECTRICAL BIOIMPEDANCE REPRODUCIBILITY AND COMPARISON WITH MULTI-GATED RADIONUCLIDE SCAN
NG, H. W. K., WALLEY, T. J., GRIME, S., CRITCHLEY, M., & BRECKENRIDGE, A. M. (1993). EJECTION FRACTION BY TRANSTHORACIC ELECTRICAL BIOIMPEDANCE REPRODUCIBILITY AND COMPARISON WITH MULTI-GATED RADIONUCLIDE SCAN. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 15(9), 651-658. Retrieved from https://www.webofscience.com/
INTERACTION OF METOPROLOL AND FLUOXETINE
WALLEY, T., PIRMOHAMED, M., PROUDLOVE, C., & MAXWELL, D. (1993). INTERACTION OF METOPROLOL AND FLUOXETINE. LANCET, 341(8850), 967-968. doi:10.1016/0140-6736(93)91265-N
Drugs in focus: 7. Misoprostol
Walley, T. J. (1993). Drugs in focus: 7. Misoprostol. Prescribers Journal, 33(2), 78-82.
Effects of dilevalol (R,R‐labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.
Walley, T., Tsao, Y., Scott, A., Mackay, E., Vandenburg, M., & Breckenridge, A. (1993). Effects of dilevalol (R,R‐labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.. British Journal of Clinical Pharmacology, 35(6), 623-628. doi:10.1111/j.1365-2125.1993.tb04192.x
Effects of dilevalol and nifedipine on heart rate, blood pressure and muscle blood flow before and after exercise in hypertensive patients
Walley, T., Tsao, Y., Scott, A., Mackay, E., Vandenburg, M., & Breckenridge, A. (1993). Effects of dilevalol and nifedipine on heart rate, blood pressure and muscle blood flow before and after exercise in hypertensive patients. In British Journal of Clinical Pharmacology Vol. 35 (pp. 86).
Generic substitution [1]
Walley, T. (1993). Generic substitution [1]. Journal of the Royal College of Physicians of London, 27(1), 93.
Health Economics in Primary Care in the UK: Containment of Drug Costs
Walley, T., & Edwards, R. T. (1993). Health Economics in Primary Care in the UK: Containment of Drug Costs. Pharmacoeconomics Pharmacoeconomics, 3(2), 100-106. doi:10.2165/00019053-199303020-00003
Impedance cardiography [letter; comment]
Ng, H., & Walley, T. (1993). Impedance cardiography [letter; comment]. British Journal of Clinical Pharmacology, 36(1), 88-89. doi:10.1111/j.1365-2125.1993.tb05900.x
Rational prescribing in primary care—a new role for clinical pharmacology? [editorial]
Walley, T. (1993). Rational prescribing in primary care—a new role for clinical pharmacology? [editorial]. British Journal of Clinical Pharmacology, 36(1), 11-12. doi:10.1111/j.1365-2125.1993.tb05884.x
Reproducibility and comparison of cardiac output measurement by transthoracic bioimpedance and thermodilution methods in critically ill patients
Ng, H. W. K., Coleman, N., Walley, T. J., Mostafa, S. M., & Breckenridge, A. M. (1993). Reproducibility and comparison of cardiac output measurement by transthoracic bioimpedance and thermodilution methods in critically ill patients. Clinical Intensive Care, 4(5), 217-221.
Therapeutic conservatism [1]
Walley, T., & Watt, A. H. (1993). Therapeutic conservatism [1]. Journal of the Royal College of Physicians of London, 27(2), 198-199.
Therapeutic conservatism [1]
Walley, T. (1993). Therapeutic conservatism [1]. Journal of the Royal College of Physicians of London, 27(3), 337-339.
1992
Current controversies in therapeutics
Walley, T. (1992). Current controversies in therapeutics. In Journal of the Royal College of Physicians of London Vol. 26 (pp. 307-311).
Different vasodilating mechanisms - Different peripheral effects?
Breckenridge, A., Roberts, D., & Walley, T. (1992). Different vasodilating mechanisms - Different peripheral effects?. In Journal of Cardiovascular Pharmacology Vol. 19 (pp. S23-S26). doi:10.1097/00005344-199219001-00006
FHSA medical advisers: Friends or foes?
Walley, T., & Bligh, J. (1992). FHSA medical advisers: Friends or foes?. British Medical Journal, 304(6820), 133-134. doi:10.1136/bmj.304.6820.133
Interactions of flosequinan and xamoterol in central and peripheral haemodynamics during exercise in normal subjects
Ng, H. W. K., Walley, T., Tsao, Y., & Breckenridge, A. M. (1992). Interactions of flosequinan and xamoterol in central and peripheral haemodynamics during exercise in normal subjects. In British Journal of Clinical Pharmacology Vol. 34.
Metipranolol-induced adverse reactions: I. The rechallenge study
Akingbehin, T., Villada, J. R., & Walley, T. (1992). Metipranolol-induced adverse reactions: I. The rechallenge study. Eye Basingstoke, 6(3), 277-279. doi:10.1038/eye.1992.52
Pamidronate treatment of hypercalcaemic crisis in primary hyperparathyroidism
Morris, C., & Walley, T. (1992). Pamidronate treatment of hypercalcaemic crisis in primary hyperparathyroidism. European Journal of Internal Medicine, 3(2), 165-166.
Selective serotonin reuptake inhibitors [14]
Walley, T. (1992). Selective serotonin reuptake inhibitors [14]. British Medical Journal, 305(6852), 526.
The UK Indicative Prescribing Scheme: Background and Operation
Bligh, J., & Walley, T. (1992). The UK Indicative Prescribing Scheme: Background and Operation. Pharmacoeconomics, 2(2), 137-152. doi:10.2165/00019053-199202020-00006
1991
"Slurry lung": a report of three cases
Fahy, J. V., Walley, T., Gibney, R. T. N., McCabe, M., & Fitzgerald, M. X. (1991). "Slurry lung": a report of three cases. Thorax, 46(5), 394-395. doi:10.1136/thx.46.5.394
Allergy to penicillin [1]
Ewan, P. W., Pearson, C. R., Walley, T., Coleman, J., McSharry, C., Lewis, C., . . . Gietzen, T. W. (1991). Allergy to penicillin [1]. British Medical Journal, 302(6790), 1462-1463.
Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultrasound measurement of cardiac function in healthy volunteers.
Ng, H., Walley, T., Tsao, Y., & Breckenridge, A. (1991). Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultrasound measurement of cardiac function in healthy volunteers.. British Journal of Clinical Pharmacology, 32(3), 275-282. doi:10.1111/j.1365-2125.1991.tb03899.x
Drug interactions with OTCs
Walley, T. (1991). Drug interactions with OTCs. Practitioner, 235(1499), 170-173.
Lack of an interaction between propranolol and sumatriptan.
Scott, A., Walley, T., Breckenridge, A., Lacey, L., & Fowler, P. (1991). Lack of an interaction between propranolol and sumatriptan.. British Journal of Clinical Pharmacology, 32(5), 581-584. doi:10.1111/j.1365-2125.1991.tb03955.x
1990
ACE inhibitors and peripheral vascular disease
Walley, T., & Roberts, D. (1990). ACE inhibitors and peripheral vascular disease. Lancet, 336(8718), 810. doi:10.1016/0140-6736(90)93271-P
Adverse effects of captopril in hospital outpatients with hypertension
Walley, T., Winstanley, P., Roberts, D., Grimmer, M., Orme, M., & Breckenridge, A. (1990). Adverse effects of captopril in hospital outpatients with hypertension. Postgraduate Medical Journal, 66(772), 106-109. doi:10.1136/pgmj.66.772.106
Loperamide related toxic megacolon in Clostridium difficile colitis
Walley, T., & Milson, D. (1990). Loperamide related toxic megacolon in Clostridium difficile colitis. Postgraduate Medical Journal, 66(777), 582. doi:10.1136/pgmj.66.777.582-a
The clinical and scientific basis of drug toxicity: A report of a conference
Shah, R. R., & Walley, T. (1990). The clinical and scientific basis of drug toxicity: A report of a conference. In Journal of the Royal College of Physicians of London Vol. 24 (pp. 219-223).
1989
Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.
Walley, T. J., Woods, K. L., & Barnett, D. B. (1989). Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting.. Thrombosis and haemostasis, 61(1), 137-139. doi:10.1055/s-0038-1646542
The effects of intravenous and oral nifedipine on ex vivo platelet function.
Walley, T. J., Woods, K. L., & Barnett, D. B. (1989). The effects of intravenous and oral nifedipine on ex vivo platelet function.. European journal of clinical pharmacology, 37(5), 449-452. doi:10.1007/bf00558122
1988
The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects.
Walley, T. J., Heagerty, A. M., Woods, K. L., Bing, R. F., Pohl, J. E., & Barnett, D. B. (1988). The haemodynamic effects of intravenous nifedipine in normotensive and hypertensive subjects.. Journal of human hypertension, 2(3), 199-202.
EYE PAIN WITH NIFEDIPINE
KELLY, S. P., & WALLEY, T. J. (1988). EYE PAIN WITH NIFEDIPINE. BRITISH MEDICAL JOURNAL, 296(6633), 1401. doi:10.1136/bmj.296.6633.1401-a
Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects.
Walley, T. J., Heagerty, A. M., Woods, K. L., Bing, R. F., Pohl, J. E., & Barnett, D. B. (1988). Acute inotropic effects of intravenous nifedipine and its vehicle compared with saline: a double-blind study of systolic time intervals in normal subjects.. British journal of clinical pharmacology, 25(2), 187-193. doi:10.1111/j.1365-2125.1988.tb03290.x
Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects
Kelly, S. P., & Walley, T. J. (1988). Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects. British Journal of Ophthalmology, 72(3), 216-218. doi:10.1136/bjo.72.3.216
Postmarketing surveillance of enalapril I
Millson, D., Walley, T., Blowers, D., Chalmers, D., Morice, A., Higenbottam, T. W., & Brown, T. W. (1988). Postmarketing surveillance of enalapril I. British Medical Journal, 297(6658), 1269-1270.
1987
Nifedipine infusion in acute myocardial infarction: experience in twelve patients.
Walley, T. J., Heagerty, A. M., Woods, K. L., Bing, R. F., Pohl, J. E., & Barnett, D. B. (1987). Nifedipine infusion in acute myocardial infarction: experience in twelve patients.. Clinical cardiology, 10(12), 800-803. doi:10.1002/clc.4960101205
Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.
Walley, T. J., Heagerty, A. M., Woods, K. L., Bing, R. F., Pohl, J. E., & Barnett, D. B. (1987). Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.. British journal of clinical pharmacology, 23(6), 693-701. doi:10.1111/j.1365-2125.1987.tb03103.x
Nitrite-induced methaemoglobinaemia
Walley, T., & Flanagan, M. (1987). Nitrite-induced methaemoglobinaemia. Postgraduate Medical Journal, 63(742), 643-644. doi:10.1136/pgmj.63.742.643
1985
Autoregulation of tissue blood flow in essential hypertension
Blake, S., Carey, M., McShane, A., & Walley, T. (1985). Autoregulation of tissue blood flow in essential hypertension. Dimensions of Critical Care Nursing, 7(6), 1003-1007. doi:10.1161/01.hyp.7.6.1003
1977
Substrate effects in prostaglandin biosynthesis in vesicular membranes [proceedings].
Harrington, C. F., Tritschler, C., McGrath, A., Walley, T. J., Harrington, M. G., & Connolly, J. F. (1977). Substrate effects in prostaglandin biosynthesis in vesicular membranes [proceedings].. Biochemical Society transactions, 5(6), 1700-1702. doi:10.1042/bst0051700